FEMASYS INC
FEMY · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $1.77
- Today’s Low
- $1.67
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.00
- Previous Close
- $1.75
- Volume
- 66.52K
- Market Cap
- $14.65M
- P/E Ratio
- --
- EPS
- $-4.41
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL INSTRUMENTS & SUPPLIES
- Headquarters
- 3950 JOHNS CREEK COURT, SUWANEE, GA, UNITED STATES, 30024
- Country
- US
- Listing Date
- 2021-06-18
- Fiscal Year End
- December
- Shares Outstanding
- 3.02M
- CIK
- 0001339005
- Website
- www.femasys.com
Femasys Inc. is a pioneering medical technology company focused on revolutionizing women's healthcare with its proprietary, non-surgical solutions for diagnosing and treating gynecological conditions, including uterine fibroids and contraception. By addressing significant unmet needs in women's health, Femasys is positioned to benefit from the growing demand for minimally invasive treatments, which enhance patient outcomes and improve healthcare efficiency. The company's innovative approach aims to set new standards of care, reinforcing its commitment to transforming the landscape of women's health and solidifying its role as a key player in this vital and expanding market.
Financial Metrics
Revenue
2026-06-30
$331.82K
2026-03-31
$424.88K
2025-12-31
$813.38K
2025-09-30
$729.39K
Operating Expenses
2026-06-30
$5.03M
2026-03-31
$4.28M
2025-12-31
$5.55M
2025-09-30
$3.87M
Net Income
2026-06-30
-$4.46M
2026-03-31
$328.64K
2025-12-31
-$3.95M
2025-09-30
-$4.19M
Net Profit Margin
2026-06-30
-1.34K%
2026-03-31
77.34%
2025-12-31
-485.66%
2025-09-30
-575.11%
Earnings Per Share
2026-06-30
$-1.33
2026-03-31
$-1.46
2025-12-31
$-0.20
2025-09-30
$-2.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.08M
2026-03-31
$1.22M
2025-12-31
-$3.32M
2025-09-30
-$3.45M
Effective Tax Rate
2026-06-30
-0.01%
2026-03-31
61.15%
2025-12-31
-0.13%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $331.82K | $424.88K | $813.38K | $729.39K |
| Operating Expenses | $5.03M | $4.28M | $5.55M | $3.87M |
| Net Income | -$4.46M | $328.64K | -$3.95M | -$4.19M |
| Net Profit Margin | -1.34K% | 77.34% | -485.66% | -575.11% |
| Earnings Per Share | $-1.33 | $-1.46 | $-0.20 | $-2.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.08M | $1.22M | -$3.32M | -$3.45M |
| Effective Tax Rate | -0.01% | 61.15% | -0.13% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.